Medicare Enrolled
Dr. Wayne Hey, D.O.
Urology Physician · Fort Worth, TX
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Hey from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Hey?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Hey
Dr. Wayne Hey is an urology physician in Fort Worth, TX, with 18 years of NPI registration. Based on federal Medicare data, Dr. Hey performed 4,822 Medicare services across 2,277 unique beneficiaries.
Between the years covered by Open Payments, Dr. Hey received a total of $9,717 from 52 pharmaceutical and/or device companies across 458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Hey is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 24% volume in TX
$9,717 industry payments
Medicare Practice Summary
Medicare Utilization ↗4,822
Medicare services
Top 24% in TX for urology physician
2,277
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~268 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
1,077 | $4 | $15 |
| Infectious disease DNA/RNA test A laboratory test that uses a specific technique to detect the genetic material of an organism. This method amplifies the target DNA or RNA to identify the presence of the organism. |
769 | $34 | $68 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
537 | $91 | $251 |
| Genetic analysis to identify organisms A laboratory test that uses genetic analysis and an amplified probe technique to identify specific organisms. |
474 | $34 | $75 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
383 | $62 | $203 |
| Ketorolac injection, per 15 mg An injection of ketorolac tromethamine, a nonsteroidal anti-inflammatory drug, administered in doses measured per 15 mg. |
173 | $0 | $40 |
| Injection, garamycin, gentamicin, up to 80 mg | 167 | $2 | $40 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
118 | $184 | $410 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
98 | $8 | $45 |
| Complete pelvic ultrasound An imaging test using sound waves to create pictures of the organs and structures within the pelvis. |
84 | $56 | $205 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
81 | $6 | $149 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
75 | $81 | $250 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
64 | $116 | $331 |
| VRE nucleic acid detection test A laboratory test that uses amplified probe techniques to detect vancomycin-resistant Enterococcus (VRE) DNA in a patient sample. |
57 | $34 | $189 |
| Group B Strep DNA test A laboratory test that uses DNA amplification to detect the presence of Group B Streptococcus bacteria. |
55 | $34 | $269 |
| Staphylococcus aureus DNA test A laboratory test that uses DNA amplification to detect the presence of Staphylococcus aureus bacteria in a sample. |
54 | $34 | $193 |
| Non-needle muscle activity measurement of bladder and bowel openings This procedure measures and records the electrical activity of muscles at the bladder and bowel openings without using needles. |
48 | $26 | $483 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
48 | $27 | $74 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
42 | $129 | $249 |
| Complex urodynamic pressure flow study A test that measures the pressure of urine flow in the bladder during voiding to evaluate how well the bladder and urethra are functioning. |
40 | $285 | $600 |
| Complicated insertion of bladder tube | 39 | $121 | $300 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
32 | $16 | $23 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
31 | $91 | $250 |
| Cystourethrogram An X-ray imaging procedure performed by injecting contrast material through the bladder and urethra to visualize the urinary tract. |
25 | $27 | $200 |
| Complex urodynamic pressure measurement A test that measures the pressure of urine flow in the bladder along with urethral and voiding pressures. |
25 | $306 | $600 |
| Abdominal device insertion with pressure and urine flow study A procedure involving the placement of a device into the abdomen, accompanied by a study to measure pressure and urine flow rate. |
25 | $156 | $436 |
| Radiologist review of ureter or urethra image A radiologist reviews images of the ureter or urethra to evaluate the structures. |
25 | $32 | $80 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
25 | $62 | $250 |
| Office visit, established patient (10-19 min) An office visit for an existing patient lasting 10 to 19 minutes. The visit involves medical evaluation and management of the patient's condition. |
21 | $36 | $150 |
| Urethral dilation using endoscope A procedure to widen the urethra using a thin, lighted tube called an endoscope. This helps to open a narrowed urethral passage. |
20 | $264 | $594 |
| Bladder irrigation and/or instillation This procedure involves flushing the bladder with fluid to clear it or introducing medication directly into the bladder. |
18 | $58 | $200 |
| Antimicrobial drug evaluation Assessment of the patient's response to antibiotic, antifungal, or antiviral therapy. |
17 | $7 | $476 |
| Assessment of muscle signal of pelvic nerves This procedure evaluates the electrical activity or signal of muscles innervated by the pelvic nerves. It is used to assess the functional status of these nerves and the muscles they control. |
16 | $110 | $500 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
16 | $61 | $153 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
15 | $99 | $250 |
| Shock wave crushing of kidney stones A procedure that uses shock waves to break kidney stones into smaller pieces so they can pass more easily from the body. |
14 | $453 | $1,200 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
14 | $257 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.3% high complexity
13.7% medium
86.0% routine
Industry Payment Transparency
Open Payments through 2024 ↗$9,717
Total received (2018-2024)
Avg $1,388/year across 7 years
Top 20% in TX for urology physician
52
Companies
458
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,548 (98.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$170 (1.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$2,652
2023
$1,875
2022
$1,667
2021
$1,132
2020
$781
2019
$706
2018
$904
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Janssen Biotech, Inc.
$2,345
Astellas Pharma US Inc
$1,438
Endo Pharmaceuticals Inc.
$911
Sumitomo Pharma America, Inc.
$395
PFIZER INC.
$391
Dendreon Pharmaceuticals LLC
$339
Myovant Sciences Inc.
$301
Avadel Specialty Pharmaceuticals, LLC
$223
Antares Pharma, Inc.
$221
Mission Pharmacal Company
$185
Janssen Scientific Affairs, LLC
$175
UROVANT SCIENCES INC
$168
Progenics Pharmaceuticals, Inc.
$165
Amgen Inc.
$162
Accord Healthcare, Inc.
$161
ConvaTec Inc.
$161
Endo USA, Inc.
$143
Johnson & Johnson Health Care Systems Inc.
$141
Boston Scientific Corporation
$122
Bayer Healthcare Pharmaceuticals Inc.
$120
Clarus Therapeutics Inc.
$119
180 Medical, Inc.
$100
ABBVIE INC.
$95
ACCORD HEALTHCARE, INC.
$92
Medtronic, Inc.
$83
Blue Earth Diagnostics Limited
$74
Bayer HealthCare Pharmaceuticals Inc.
$67
Merck Sharp & Dohme LLC
$66
Merck Sharp & Dohme Corporation
$64
UROGEN PHARMA, INC.
$61
Medtronic USA, Inc.
$57
Tolmar, Inc.
$55
PROCEPT BioRobotics Corporation
$54
Supernus Pharmaceuticals, Inc.
$50
MIMEDX Group, Inc.
$48
Foundation Medicine, Inc.
$45
Acerus Pharmaceuticals Corporation
$45
Axonics, Inc.
$39
AngioDynamics, Inc.
$33
Olympus America Inc.
$33
Travere Therapeutics, Inc.
$26
Teleflex LLC
$20
IsoRay, Inc
$19
Metuchen Pharmaceuticals
$15
Cook Medical LLC
$14
Retrophin, Inc.
$14
Rochester Medical Corporation
$13
AbbVie Inc.
$13
MISSION PHARMACAL COMPANY
$13
Abbott Laboratories
$12
MEDIVATION FIELD SOLUTIONS LLC
$12
NxThera, Inc.
$1
Top 3 companies account for 48.3% of total payments
Associated products mentioned in payments ›
(815) Thiola · AQUABEAM SYSTEM · AVEED · Axumin · BALVERSA · Brachytherapy Source · Bulkamid · CAMCEVI · EDEX · ERLEADA · Erleada · FOUNDATIONONE · GEMTESA · GENERAL BPH · GENERAL - BPH · GENERAL - VASCULAR INTERVENTION · GENTLECATH · GENTLECATH GLIDE · INTERSTIM · JATENZO · JELMYTO · KEYTRUDA · LITHOVUE · LUPRON DEPOT · LYNPARZA · MYRBETRIQ · Myrbetriq · NANOKNIFE · NOCDURNA · NURO · Natesto · Noctiva · Nubeqa · ORGOVYX · OTREXUP · POSLUMA · PROVENGE · PYLARIFY · Prolia · RESONANCE · Rezum · STELARA · Stendra · URIBEL · URIBEL TABS · UROLIFT · Uribel · VESICARE · Veozah · XIAFLEX · XTANDI · XYOSTED · Xtandi · iTIND System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $202 per 100 Medicare services performed
Geographic Context
Urology physicians within 10 mi
94
Per 100K population
4.4
County median income
$81,905
Nearest hospital
JPS HEALTH NETWORK
3.0 mi
3.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Hey is a clinical cardiology specialist, with above-average Medicare volume (top 24% in TX), with low-engagement industry engagement in the top 20% of TX peers, with 18 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Hey experienced with manual urinalysis with microscopic examination?
Based on Medicare claims data, Dr. Hey performed 1,077 manual urinalysis with microscopic examination services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Hey receive payments from pharmaceutical companies?
Yes. Dr. Hey received a total of $9,717 from 52 companies across 458 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Hey's costs compare to other urology physicians in Fort Worth?
Dr. Hey's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Hey) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in Fort Worth
Browse urology physicians in Fort Worth ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in TX
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in TX
Which TX urology physicians receive the most from drug and device companies.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Endo Pharmaceuticals Inc. Payments to Doctors
See all physicians who received payments from Endo Pharmaceuticals Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology